Your search for

15 results were returned

  1. Legal news
    05 February 2019
    "Effective enforcement of EU competition rules in the pharmaceutical law remains a matter of high priority…"
    www.twobirds.com/en/news/articles/2019/global/effective-enforcement-of-eu-competition-rules-in-pharmaceutical-law

    So notes the Commission's report on competition enforcement in the pharmaceutical sector (2009-2017) published at the end of January 2019.

  2. Legal news
    08 May 2019
    Manufacturing and stockpiling waiver set to limit rights of holders of SPCs for medicines
    www.twobirds.com/en/news/articles/2019/global/manufacturing-and-stockpiling-waiver-set-to-limit-rights-of-holders-of-spcs-for-medicines

    On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").

  3. Legal news
    22 November 2019
    Access to toxicity study reports and protection of commercial interests
    www.twobirds.com/en/news/articles/2019/uk/access-to-toxicity-study-reports-and-protection-of-commercial-interests

    Gerard Hogan, Advocate General at the Court of Justice of the European Union (“CJEU”) recently delivered an opinion in the pending case between MSD Animal Health Innovation (“MSD”), Intervet international (“Intervet”) ...

  4. Legal news
    02 July 2019
    Transfer of value: amendments to the French “anti-gift” provisions by the draft Health Act
    www.twobirds.com/en/news/articles/2019/global/transfer-of-value-amendments-to-the-french-anti-gift-provisions-by-the-draft-health-act

    The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the health sector are allowed to provide advantages, in cash or in kind, to healthcare professionals ("HCPs”)

  5. Legal news
    02 December 2019
    The French Health Data Hub becomes reality
    www.twobirds.com/en/news/articles/2019/france/the-french-health-data-hub-becomes-reality

    The French Health Data Hub was born officially with the publication on 30 November 2019 of a ministerial decision (arrêté).

  6. Legal news
    15 November 2018
    Supreme Court defines plausibility in the context of sufficiency
    www.twobirds.com/en/news/articles/2018/uk/supreme-court-defines-plausibility-in-the-context-of-sufficiency

    A majority postulates a new "outward presentation test" to deal with the infringement of second medical use patents.

  7. Twobirds news
    01 June 2020
    Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB
    www.twobirds.com/en/news/press-releases/2020/czech-republic/bird-and-bird-law-firm-advised-indian-vaccine-manufacturer-serum-institute-of-india-pvt-ltd

    Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...

  8. Legal news
    30 September 2019
    Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts
    www.twobirds.com/en/news/articles/2019/germany/bird-and-bird-secures-win-in-preliminary-injunction-patent-case-before-the-dusseldorf-courts

    On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...

  9. Legal news
    24 May 2019
    Can CRISPR save the Cavendish?
    www.twobirds.com/en/news/articles/2019/global/can-crispr-save-the-cavendish

    The world's most popular banana is dying. Scientists are using the gene-editing mechanism CRISPR to try and save it from extinction.

  10. Twobirds news
    13 May 2020
    Bird & Bird advised Materia on its acquisition of German licensed medicinal cannabis distributor Cannaktiv
    www.twobirds.com/en/news/press-releases/2020/germany/bird-beraet-materia-beim-erwerb-von-cannaktiv

    Bird & Bird LLP advised Materia on the acquisition of all shares in German licensed medicinal cannabis distributor Cannaktiv GmbH. The deal provides Materia – an international manufacturer and distributor of medicinal ...